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REPORT
Homozygous Mutations in Fibroblast Growth Factor 3 Are
Associated with a New Form of Syndromic Deafness
Characterized by Inner Ear Agenesis, Microtia, and Microdontia
Mustafa Tekin, Burcu O¨ztu¨rk His¸mi, Suat Fitoz, Hilal O¨zdag˘, Filiz Bas¸ak Cengiz, Aslı Sırmacı,
I˙dil Aslan, Bora I˙nceog˘lu, E. Berrin Yu¨ksel-Konuk, Seda Tas¸ır Yılmaz, O¨ztan Yasun, and Nejat Akar
We identified nine individuals from three unrelated Turkish families with a unique autosomal recessive syndrome char-
acterized by type I microtia, microdontia, and profound congenital deafness associated with a complete absence of inner
ear structures (Michel aplasia). We later demonstrated three different homozygous mutations (p.S156P, p.R104X, and
p.V206SfsX117) in the fibroblast growth factor 3 (FGF3) gene in affected members of these families, cosegregating with
the autosomal recessive transmission as a completely penetrant phenotype. These findings demonstrate the involvement
of FGF3 mutations in a human malformation syndrome for the first time and contribute to our understanding of the
role this gene plays in embryonic development. Of particular interest is that the development of the inner ear is completely
disturbed at a very early stage—or the otic vesicle is not induced at all—in all of the affected individuals who carried
two mutant FGF3 alleles.
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The incidence of congenital sensorineural hearing loss in
developed countries is 1.33–1.86 per 1,000 newborns.1 Ra-
diological abnormalities of the inner ear are detected in
∼30% of these children.2,3 Complete bony and membra-
nous aplasia of the inner ear, which was first described by
Michel in 18634 and is referred to as “Michel aplasia,” is
among the rare examples of inner ear anomalies. Deafness,
sometimes associated with inner ear anomalies, is a phe-
notypic component of 1400 multiple-malformation syn-
dromes. We have delineated a new autosomal recessively
inherited human malformation syndrome in three unre-
lated Turkish families including nine affected individuals
ranging in age from 7 to 42 years (figs. 1 and 2). Three
major phenotypic effects noted in all affected individuals
were profound congenital sensorineural deafness, type I
microtia with shortening of auricles above the crura of
antihelix, and microdontia with widely spaced teeth. In
addition, anteverted ears were present in seven of the nine
affected individuals (fig. 2). Computed tomography (CT)
of the temporal bones in all patients showed the complete
absence of inner ear structures bilaterally, including coch-
lea, vestibule, and semicircular canals (Michel aplasia) with
normal-appearing middle ear structures (figs. 3 and 4). In
addition to CT examination, a cranial magnetic resonance
imaging of the cerebellopontine angle showed the bilateral
absence of cochleovestibular nerve with otherwise normal
cerebral and cerebellar structures in one affected patient
(fig. 5). Physical development was normal in all patients.
The standing heights of two patients were above the 97th
percentile for normal Turkish children at the same ages.
A delay in gross motor skills during infancy, presumably
caused by impaired balance, was noted in all patients.
Seven affected subjects were students at local schools for
the hearing impaired and had no difficulties in writing or
reading. All children were reported to be average or above
average students, with no problems communicating by
use of an indigenous sign language. Individual III:3 in
family B had a paying job and was responsible for the
support of his family. Therefore, the affected subjects ap-
peared to have normal cognitive abilities. Complete blood
counts, serum electrolytes, and results of liver and kidney
function tests were all within normal limits, and the lac-
rimal canals and saliva production were normal. There
were no limb anomalies on clinical examination or on X-
rays. Renal ultrasound in one girl (family A, IV:10) showed
unilateral stenosis of ureteropelvic junction. Another girl
(family C, II:1) was operated on for strabismus at a young
age and wore glasses for hypermetropia. Ophthalmoscopic
evaluation of all cases showed normal retinal findings. A
supernumerary upper lateral incisor was present, with ab-
sence of the first premolar on the same side in one person
(family A, IV:5). Some affected individuals had peg-shaped
lateral incisors and loss of tooth heights because of phys-
ical contact between the upper and lower teeth. Mild mi-
crognathia was noted in some patients. Excessive caries
were noted only in the 42-year-old male (family B, III:3),
probably reflecting poor oral hygiene (fig. 2). Peripheral
blood chromosomes were normal in one patient from each
family. None of the parents had any of the above-men-
tioned clinical findings. The presence of auriculodental
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Figure 1. Pedigrees of three unrelated Turkish families with the syndrome described in this report. Plus and minus signs indicate the
presence and absence of the identified mutation, respectively. Mutations were c.466TrC, c.310CrT, and c.616delG, in families A, B,
and C, respectively. Although consanguinity was denied between I:1 and I:2 in family C and between II:5 and II:6 in family B, parents
originated from a small, isolated village in both families. Consanguinity between II:3 and II:4 in family A is more distant than third-
degree cousins.
findings was somewhat suggestive of the lacrimoauriculo-
dentodigital (LADD) syndrome (MIM 149730). However,
the lacrimal and digital findings and dominant transmis-
sion of LADD5 were absent in our patients, who clearly
showed autosomal recessive inheritance. A search of OMIM
and POSSUM with the keywords “microtia,” “deafness,”
“absence of inner ear,” “Michel aplasia,” and “microdon-
tia” did not match other recognized syndromes. A report
of a sporadic case with Michel aplasia, microdontia, and
microtia was noted during a search in PubMed.6 We con-
cluded that the phenotypic findings described in our pa-
tients and in the child previously reported by Hersh et al.6
represent a distinct autosomal recessive multiple-malfor-
mation syndrome.
After obtaining written informed consent using forms
approved by the Ankara University Ethics Committee (de-
cision no. 85–2215; January 30, 2006), we obtained DNA
samples from available family members. Genomic DNA
was extracted from peripheral blood by a standard phenol
chloroform method. Because of the phenotypic similari-
ties between LADD syndrome and the new syndrome, we
initially suspected that a homozygous mutation involving
a member of the fibroblast growth factor family might be
responsible. To find such a candidate gene, we genotyped
19 members of family A for 10,200 SNPs with a mean
intermarker distance of 258 kb, equivalent to 0.36 cM,
using Affymetrix GeneChip 10K Xba 142 2.0. The recom-
mendations by Affymetrix were followed throughout the
study. Experiments were performed at the Central Gen-
omics Laboratory of Ankara University Biotechnology In-
stitute. For linkage analysis, the SuperLink v1.4 and Gene-
Hunter v2.1r5 programs were used in the easyLINKAGE
Plus v4.01 beta program package written for Windows.7
An autosomal recessive inheritance model with full pen-
etrance was selected. Frequency of the disease allele was
0.001. Affymetrix Marshfield SNP data were used for map-
ping information of the genotyped SNPs. Raw data ob-
tained from GeneChip were converted to a Microsoft Excel
table, and linkage analysis was performed on a personal
computer located at the Division of Clinical Molecular
Pathology and Genetics of Ankara University. These anal-
yses did not provide a significant LOD score for any tested
marker (fig. 6). Because the family contained consanguin-
eous marriages, we looked for homozygous SNP blocks
that were shared by all affected subjects. This approach,
although empirical, has been shown to be effective for iden-
tifying regions of identity by descent (IBD) during the
evaluation of genomewide SNP data.8,9 It has been shown
that the greater the number of affected individuals who
have a shared homozygous region and the greater the size
Figure 2. Clinical photographs of the affected nine subjects. Note the presence of type I microtia and microdontia in all patients. A
long face was seen in most affected subjects, growing more pronounced as they got older. A, From left to right, V:1, V:2, IV:5, IV:8,
and IV:10 in family A. B, IV:3, IV:2, and III:3 in family B. C, II:1 in family C. The hearing members of the families have normal-
appearing teeth and no craniofacial dysmorphology.
Figure 3. A, Contiguous axial CT sections of normal temporal bone. Cochlea (white arrow), internal auditory canal (asterisk), vestibule
(black arrow), and ossicles (double white arrows) are clearly visible. B, CT images crossing through approximately the same levels,
compared with normal sections, reveal petrous bone aplasia, with absence of inner ear structures in II:1 in family C. Normal development
of middle ear cavity and ossicles (double arrow) are clearly visible. CT images in all affected subjects showed similar findings (fig. 4).
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Figure 4. Contiguous axial CT sections of normal temporal bone.
The legend is available in its entirety in the online edition of The
American Journal of Human Genetics.
Figure 5. In a patient (family C, II:1) with bilateral inner ear petrous bone aplasia and absence of inner ear structures detected on
CT (row B in fig. 3), coronal (A) and axial (B) MR images clearly show the absence of the internal auditory canal in cerebellopontine
angle compared with normal appearances (C and D). White arrows, cochleovestibular nerves.
of the region, the more likely the region is to harbor the
mutation that causes the disease.8,9 Because the exclusion
of a given locus was based on its heterozygosity, we in-
cluded all SNPs in the analysis without taking into account
their informativeness or “no call” genotypes. Visual eval-
uation of our data showed that all five affected individuals
in family A were homozygous for nine consecutive SNPs
between rs1944043 and rs2077955, corresponding to a
physical position of 62,620,442–71,886,708 bp or a span
of 9,266,266 bp (table 1), implying but not confirming
IBD for this locus. The genomic localization of FGF3 (En-
sembl accession number ENSG00000186895) is between
69,333,917 and 69,343,129 bp on 11q13. Because we pre-
viously hypothesized that a fibroblast growth factor was
involved in the pathogenesis of this syndrome and FGF3
has previously been shown to be expressed during inner
ear and tooth development,10 we considered this gene to
be a prime positional candidate instead of documenting
a formal linkage by use of genotypes of a greater number
of polymorphic markers. The three exons and intron-exon
boundaries of the FGF3 gene were PCR amplified using
specific primers designed with the Primer3 program (table
2). PCRs were performed in a total volume of 50 ml con-
taining 100 ng genomic DNA, 20 pmol each primer, 200
mM deoxynucleotide triphosphates, 1 U thermostable
DNA polymerase (Fermentas), and 1.5 mM MgCl2. Betaine
was added to increase the product yield in some reactions.
The PCR products were later purified using a DNA clean
and concentrator-5 kit (Zymo Research) and sequenced in
both directions using a dye terminator cycle sequencing
kit (Beckman Coulter) in all members of three families.
An automated sequencer (Beckman Coulter CEQ 2000XL)
was used for DNA sequencing.
We identified a homozygous c.466TrC mutation in the
third exon of FGF3 in five affected members of family A
(fig. 7). All parents were heterozygous, and unaffected rel-
atives were heterozygous or homozygous for the wild-type
allele (fig. 1). This mutation substitutes an uncharged po-
lar side chain amino acid, serine, with a nonpolar side
chain residue, proline, at codon 156 of the FGF3 protein
(p.S156P). Proline residues are known to introduce kinks
into the secondary protein structure. Serine at codon 156
is highly conserved during evolution (fig. 8). When we
repeated linkage analysis using genotypes obtained for the
c.466TrC mutation in the same 19 members of family A,
we found a two-point parametric LOD score of 3.86 at a
recombination fraction (v) of 0. (When we included addi-
tional members of this family, who became available later,
the LOD score was found to be 4.52 at ).vp 0
We found a nonsense homozygous mutation, c.310CrT
(p.R104X), in the second exon of FGF3 in all three of the
affected members of family B (fig. 7). All available parents
were heterozygous, and unaffected relatives were hetero-
zygous or homozygous for the wild-type allele in this fam-
ily (fig. 1). This mutation presumably truncates more than
one-half of the protein, apparently leaving behind a non-
functional product. Finally, in the proband of family C,
we found a homozygous c.616delG (p.V206SfsX117) mu-
tation in the third exon of FGF3 (fig. 7). The mother and
a healthy brother were found to be heterozygous for this
deletion (fig. 1). The mutation causes a frameshift starting
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Figure 6. Graphical representation of the analysis of family A.
The legend is available in its entirety in the online edition of The
American Journal of Human Genetics.
Table 1. Partial Results of 10K GeneChip Array in Family A, Showing the Chromosomal Region Containing FGF3 (q13 Band
of Chromosome 11)
dbSNP
RS ID
Physical
Position
(bp)
Genotype in
Affected Subjects Unaffected Siblings Parents
V:1 V:2 IV:8 IV:10 IV:5 V:3 V:4 IV:4 IV:6 IV:7 IV:11 IV:12 IV:13 III:5 III:6 III:7 III:8 IV:2III:2
rs953894 62518998 AA AA AA AB AA AA AB AA AA AB AA AA AA AA AA AB AA AB AB
rs1944043 62620442 AA AA AA AA AA AB AA AA AA AA AA AB AB AA AA AA AB AA AA
rs1944042 62620580 BB BB BB BB BB AB BB BB BB BB BB AB AB BB BB BB AB BB BB
rs1944086 62793443 BB 00 00 BB BB AB 00 BB AB BB 00 AB AB AB BB 00 AB BB AB
rs1404501 63041086 BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB
rs490192 64227945 AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AB
rs1938684 68986287 BB BB BB BB BB AB BB BB AA AB AB AB AB AB AB AB AB BB AA
rs1944130 69291704 AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA
FGF3 c.466 69342539 CC CC CC CC CC TT TC TC TT TC TC TC TC TC TC TC TC TC TT
rs1372108 70642724 AA AA AA AA AA 00 AA AA AA AA AA AB AB AA AA AA AB AA AA
rs2077955 71886708 BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB BB 00
rs1279293 73727821 BB BB BB BB AB BB BB AB AA BB BB BB BB AB AB BB BB BB AB
NOTE.—All genotypes are shown as they appeared in the raw data obtained from the microarray system. Homozygous genotypes in five affected
subjects are manually highlighted, and the results of mutation screening for c.466TrC in FGF3 were later incorporated. Haplotypes created using
these data are shown in figure 6.
from codon 206, resulting in the production of a com-
pletely altered protein that terminates after 116 codons.
All three mutations are likely to have significant effects
on the resulting polypeptides and most likely result in
nonfunctional proteins. The identified three mutations
were screened using PCR–Single Strand Conformational
Polymorphism (SSCP) or Amplification Refractory Muta-
tion Detection System (ARMS) protocols in 300 healthy
unrelated Turkish subjects (600 chromosomes). Primers of
FGF3 exon 2, 466sscp, 616delG, 466arms, and 310arms
were used during PCRs (table 2). In SSCP, the PCR products
were denatured at 94C, loaded onto 7% nondenaturing
polyacrylamide gels, run overnight at 4C in a vertical
gel electrophoresis system (DCode Universal Mutation de-
tection System [BioRad]), and visualized with silver stain-
ing. Homozygous and heterozygous samples were loaded
on each gel after confirmation of their differing band
structures. Concentration of MgCl2 was reduced to 1 mM
to increase specificity of ARMS reactions. PCR products
were loaded on 3% agarose gels and visualized under UV
light. Homozygous and heterozygous controls were stud-
ied as positive controls in each PCR. All experiments were
performed at the laboratories of the Clinical Molecular
Pathology and Genetics Division in the Department of
Pediatrics of Ankara University School of Medicine. None
of the samples was found to be positive for anyone of the
three screened mutations.
In the mouse, Fgf3 mRNA has been detected in the hind-
brain rhombemeres 5 and 6, adjacent to the otocysts, as
well as in the pharyngeal pouches.11 In studies of older
embryos and newborn pups, Fgf3 expression was detected
in the developing cerebellum, retina, teeth, and inner ear.11
The auricle develops from six auricular hillocks arising on
the opposed surfaces of the first and second pharyngeal
arches. The upper part of the auricle is derived from the
dorsal part of the first pharyngeal arch. Our study suggests
that the embryonic development of this area is dependent
on FGF3 signaling in humans. Early development of the
tooth appears not to be significantly affected in homo-
zygotes. However, the diameters of almost all teeth were
reduced, probably because of impaired FGF3 signaling for
growth promotion. Recent findings of heterozygous loss-
of-function mutations in genes coding Fgf-signaling pro-
teins, FGF10, FGFR2, and FGFR3, in LADD12,13 support the
idea that Fgf signaling is crucial for normal auricle and
tooth formation. Interestingly, reports of two previous
mouse knockout models of Fgf3 did not mention any dis-
turbance of the external ears or tooth development.14,15
It is surprising to observe complete absence of inner ear
structures in homozygous FGF3 mutants in the human.
The inner ear develops from the otic vesicle, which itself
is formed by the invagination of a lateral thickening (pla-
code) of the cephalic ectoderm of the vertebrate embryo,
adjacent to hindbrain, at the level of rhombomeres 5 and
6. Fgf3 is expressed in the developing hindbrain and has
been shown to be involved in the inner ear development
of a variety of vertebrates, including zebrafish, Xenopus,
chick, and mouse. Treatment of chick hindbrain cultures
containing otic placodes with reagents targeted against hu-
man FGF3 prevented the formation of otic vesicles.16 It
was also found that the ectopic expression of Fgf3 results
in the formation of ectopic otic vesicles and development
of normal inner ear structures in avian embryos.17 Despite
these reports, the phenotypes of two murine Fgf3 knock-
outs strongly argue against an essential role of Fgf3 during
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Table 2. Primers and PCR Conditions Used
Gene
Primer
Annealing
Temperature
(C)
Product
Size
(bp)Forward Reverse
FGF3:
Exon 1 5′AGCACCTCGCAGCTGTCC-3′ 5′GAGGCAGACGGTCTTTTCC-3′ 57 476
Exon2 5′-GGAGTGAGGCACCTCTCATT-3′ 5′-CCCTTGGCAAAGCATTCTAC-3′ 60 237
Exon3 5′-CTGACGCTGCCACAGTCTC-3′ 5′-CCAAGATGTCGCCAGGAG-3′ 55 493
466sscp 5′-ATCCACGAGCTGGGCTATAA-3′ 5′-CAGGGAGGACTTCTGTGTGC-3′ 58 171
616delG 5′-CAGAAGTCCTCCCTGTTCCT-3′ 5′-AGTCTCGAAGCCTGAACGTG-3′ 58 173
466arms_mutant 5′-CCGAGAGACTGTGGTACGTGC-3′ 5′-GCAGCCCACTCTGTAGCTG-3′ 61 150
466arms_normal 5′-CCGAGAGACTGTGGTACGTGT-3′ 5′-GCAGCCCACTCTGTAGCTG-3′ 60 150
310arms_mutant 5′-GCCATGAACAAGAGGGGAT-3′ 5′- CGGAGCAGCCTCTAACAGAC-3′ 60 223
310arms_normal 5′-GCCATGAACAAGAGGGGAC-3′ 5′- CGGAGCAGCCTCTAACAGAC-3′ 60 223
FGF8:
Exon 3 5′-TACTTAAAAGCGCCCTGCTC-3′ 5′-CAGCCCAGGATGAACGAG-3′ 62 154
Exon 4 5′-GGTGTATTGTGTATTTTTCAATTTCC-3′ 5′-TCCCACAAGCTACCTTCAGC-3′ 58 241
Exon 5 5′-CTTTGGAGCAGTTGCTGCTGG-3′ 5′-AGCCCAGGACTGTCTTGGAGG-3′ 60 283
Exon 6 5′-CCATGTGTCACTGCTGCCTGG-3′ 5′-GGTGCCCTACAGGATGAGCC-3′ 62 563
FGF10:
Exon 1 5′-TGCCTTGCATCGGTTCTTACC-3′ 5′-ATTTAGCTGGCCACATCTGG-3′ 60 493
Exon 2 5′-TTGCTGGAAATACTTGCCGGG-3′ 5′-AAGCTATCCGGTGTCTGGAGG-3′ 60 383
Exon 3 5′-CAAACAGAATCCTTGGACTGG-3′ 5′-CTTGGCAAAAGAGCCATTGG-3′ 60 348
Figure 7. The c.466TrC (p.S156P), c.310CrT (p.R104X), and c.616delG (p.V206SfsX117) mutations. Arrows and lines indicate the
mutation points.
induction of the otic vesicle. In the first reported knockout
model, some of the homozygous mutants had normal
hearing but the majority developed hearing loss from in-
ner ear anomalies related to the improper formation of
the endolymphatic sac and duct.14 Another mutant lack-
ing the entire Fgf3 coding region showed no evidence for
severe defects either during inner ear development or in
the mature sensory organ, suggesting the functional in-
volvement of other Fgf family members during its forma-
tion.15 Recent experiments in the mouse have documented
the involvement of Fgf10 and Fgf8 in inner ear induction
and early development, showing that double null mutants
of Fgf3 and Fgf10 or Fgf8 result in complete agenesis of
the otic vesicles.18,19 Because of the inconsistent pheno-
types observed in the mouse knockouts and the remark-
ably consistent effects observed in our three families, we
explored the possible involvement of other FGF genes in
the pathogenesis of this new syndrome. Sequencing of the
exons of human FGF8 and FGF10 genes in one affected
subject from each family failed to reveal any sequence
alterations (table 2). The monogenic autosomal recessive
segregation of three FGF3 mutations in our families thus
makes the involvement of other genes unlikely. We con-
clude that FGF3 signaling is necessary for the early de-
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Figure 8. Serine at position 156 of Fgf3 is conserved in a variety
of organisms from fish to frogs to humans. Data were obtained
using protein-protein BLAST at the National Center for Biotech-
nology Information Web site.
velopment of the inner ear in humans and, on the basis
of the previous studies described above, that this require-
ment differs from the mouse.
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